Moore’s Sicko stirs controversy
June 13, 2007Sales and Marketing
Michael Moore's latest film opens at cinemas this month and has predictably raised passions with its critical dissection of the …
Avandia scare casts doubt over its future for Alzheimer’s
June 13, 2007Sales and Marketing Avandia, diabetes, safety
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
ProStrakan begins pan-European launch campaign with Tostran
June 11, 2007Sales and Marketing
ProStrakan has unveiled Tostran in the UK, the first in a pan-European programme of product launches.Tostran is a testosterone replacement …
Latest news from Datamonitor
June 8, 2007Research and Development, Sales and Marketing
Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …
Scientists hail new gene discovery a landmark
June 7, 2007Research and Development
DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …
Quintiles invests
June 7, 2007Research and Development
Contract research organisation Quintiles is to spend £7.5 million (€11 million) on a new home for its Scottish product development …
Amgen boosts pipeline with spending spree
June 7, 2007Research and Development, Sales and Marketing
Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …
Sanofi supports Gardasil with disease awareness campaign
June 7, 2007Medical Communications
Sanofi Pasteur MSD has launched an awareness campaign to encourage women to talk about cervical cancer, the human papillomavirus and …
MHRA investigates links in spate of counterfeits
June 6, 2007Manufacturing and Production
Counterfeit versions of a prostate cancer drug have prompted the MHRA to issue its third alert about fake drugs in …
BMS launches next generation arthritis treatment Orencia
June 6, 2007Sales and Marketing
Bristol-Myers Squibb has launched its next generation rheumatoid arthritis treatment Orencia in the UK, offering patients a novel way of …
Bavarian Nordic secures $1.6 billion deal with US government
June 6, 2007Sales and Marketing
Danish company Bavarian Nordic has secured a massive new contract to provide the US with millions of doses of smallpox …
HCA launches media relations best practice guide
June 5, 2007Medical Communications
The Healthcare Communications Association has unveiled a new guide to working with the media, the first in a series of …
Product roundup from Datamonitor
June 4, 2007Sales and Marketing
Celsion completes enrolment in phase I liver cancer studyCelsion has completed its phase I dose escalation study, using ThermoDox, to …
Clew to promote Novartis’ Aclasta
May 31, 2007Medical Communications
Novartis has appointed Clew Communications to run a pre-launch and launch PR campaign for its new osteoporosis drug.Aclasta (zoledronic acid) …
NICE approves Pfizer’s Champix
May 31, 2007Pfizer's first-in-class smoking cessation drug Champix has received approval from NICE one month before England's smoking ban comes into effect.Champix …
China’s former medicines regulator sentenced to death
May 31, 2007Sales and Marketing
The former head of China's medicines regulator has been sentenced to death after being found guilty of taking bribes to …
Genzyme buys cancer specialists Bioenvision
May 31, 2007Research and Development
Genzyme is to spend $345 million on acquiring specialist pharma company Bioenvision and its oncology portfolio.Genzyme already co-markets with Bioenvision …
Avandia safety concerns hit GSK shares
May 31, 2007Sales and Marketing
Shares in GSK have taken another hit after news that US prescribers have turned away from diabetes drug Avandia in …
Product roundup from Datamonitor
May 29, 2007Sales and Marketing
ADHD drug as effective in boys as girls, says ShireUK pharmaceutical company Shire has said that results from a study …
Industry outlines concerns with NICE to Parliament
May 24, 2007NICE's shortfalls have compromised public confidence in the cost and clinical-effectiveness body, the pharmaceutical industry has told MPs.The comments were …
Latest content
FibroFind appoints Lee Borthwick as CEO
